secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sight Sciences, Inc. (SGHT)
CIK:        0001531177
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0000950170-25-105012
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sight Sciences Q2 2025 revenue $19.6M (-8% YoY), raises FY25 revenue guidance to $72-76M
--------------------------------------------------------------------------------

- Net loss $11.9M ($0.23 loss per share) vs $12.3M loss in prior year.
- Surgical Glaucoma revenue $19.2M (-5% YoY); ordering accounts hit record 1,174, up 4%.
- Dry Eye revenue fell to $0.3M from $1.1M as company focuses on reimbursed TearCare access.
- Adjusted operating expenses $24.4M, down 8% YoY; reaffirmed FY25 guidance of $101-105M.
- Tariff exposure on China products reduced from prior estimate of $3.5-4.5M to $1.0-1.5M for FY25.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531177/000095017025105012/0000950170-25-105012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531177/000095017025105012/sght-20250807.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-105012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer